Kestra Medical's Growth Paradox: A Cautionary Tale for Investors The latest SEC filing from Omega Fund Management has sent shockwaves through the investment community.
The firm trimmed its stake in Kestra Medical Technologies by 25%, leaving many to wonder if it's losing faith in the company's growth prospects.
Kestra Medical's revenue growth is a remarkable achievement, with the company posting a 63% year over year increase in its most recent quarter.